AUROPHARMA

, USFDA Inspection & Specialty Fertiliser

**

:** USFDA completed a routine inspection at its U.S. subsidiary **Lannett Company LLC**, with **four procedural observations**. The company is required to submit its compliance response to the USFDA within the stipulated timeline. **Stock Commentary:** **Neutral to Mildly Negative;** four observations create a near-term regulatory overhang, but the impact will depend on the company's response and subsequent USFDA assessment. No immediate business disruption has been indicated. **Deepak Fertilisers, Coromandel & SML:** Companies are increasingly focusing on **specialty nutrients and fertilisers**, where nutrient-use efficiency can be significantly higher than conventional urea. Urea efficiency is estimated at around **30–40%**, compared with **80–85% for specialty fertilisers**, creating scope for wider adoption. ** !DEEPAKFERT– Stock Commentary:** **Positive;** increasing focus on specialty nutrients can support demand for value-added fertiliser products and improve the company's long-term growth and margin profile. **Coromandel International – Stock Commentary:** **Positive;** rising adoption of high-efficiency specialty fertilisers can strengthen the company's product mix and support growth in value-added agricultural inputs. **SML – Stock Commentary:** **Positive;** the shift toward efficient specialty nutrients provides an opportunity to expand its presence in higher-value fertiliser segments and improve long-term revenue visibility.